SEBI Debarred Entities

The SEBI debarred entities list includes individuals and organizations that have been prohibited by the securities and exchange board of India (SEBI) from participating in securities markets. This action is typically taken due to violations of regulatory guidelines or laws related to securities trading and investment.

Mitigate risk with our comprehensive screening solutions for your AML and sanctions compliance.
11,559 Entities in SEBI Debarred Entities
Entity NameEntity TypeEffective DateStatus

Wasankar wealth management ltd

CompanyAug 27, 2014inactive

Wasankar wealth management ltd

CompanyAug 27, 2014inactive

Raghukul diam pvt ltd sanjay tiwari

CompanyApr 23, 2009inactive

Raghukul diam pvt ltd sanjay tiwari

CompanyJan 16, 2023inactive

Venmax drugs and pharmaceuticals limited

CompanyJul 14, 2021inactive

Inayata constructions private limited

CompanyMar 24, 2023inactive

Real agri industries services limited

CompanyMar 20, 2015inactive

Primavalue capital advisors pvt ltd

CompanySep 6, 2017inactive

Primavalue capital advisors pvt ltd

CompanySep 5, 2017active

Amrapali aadya trading investment pvt ltd

CompanyAug 22, 2017active

FAQs

Why is compliance with the Sanctioned Providers by The Defense Health Agency of United States (DHA) necessary?

Compliance with the Sanctioned Providers List published by the Defense Health Agency (DHA) is crucial for maintaining the integrity and security of healthcare services. These sanctions are implemented to protect beneficiaries from entities that may engage in fraudulent or unsafe practices. Adherence ensures that healthcare providers are not only meeting legal and regulatory standards but also safeguarding public health. Failing to comply can result in serious legal implications, financial penalties, and a diminished quality of care for those who rely on DHA services.

Which companies should comply with Sanctioned Providers by The Defense Health Agency of United States (DHA)?

The Sanctioned Providers List by the Defense Health Agency (DHA) primarily impacts healthcare organizations, including hospitals, clinics, and pharmaceutical companies. These entities must comply to ensure they do not engage with individuals or organizations that pose risks to patient safety or violate federal regulations. Compliance protects public health and maintains the integrity of the healthcare system while avoiding legal repercussions.